Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche begins building $700M obesity drug manufacturing facility in N.C. - Fierce Pharma
Roche begins building $700M obesity drug manufacturing facility in N.C. Fierce Pharma
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
Lonza lifts forecast as performance rebounds under new strategy The Pharma Letter
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling Fierce Pharma
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing Pharmaceutical Technology
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US - Pharmaceutical Technology
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US Pharmaceutical Technology
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
Illumina to buy SomaLogic in deal worth up to $425M BioPharma Dive
Roche follows peers with $50B investment in US manufacturing, research sites - FirstWord Pharma
Roche follows peers with $50B investment in US manufacturing, research sites FirstWord Pharma
Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing - Express Pharma
Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing Express Pharma
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
Ethris and Lonza focus on mRNA respiratory condition vaccines Pharmaceutical Technology
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines Contract Pharma
Lonza Implements Streamlined Operating Model - Contract Pharma
Lonza Implements Streamlined Operating Model Contract Pharma
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC - PR Newswire
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC PR Newswire
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 Contract Pharma
Tech and service specialist Cytiva charts 85 layoffs at Massachusetts production site - Fierce Pharma
Tech and service specialist Cytiva charts 85 layoffs at Massachusetts production site Fierce Pharma
Revolutionary approaches to drug design: how AI is transforming life sciences - Pharmaceutical Technology
Revolutionary approaches to drug design: how AI is transforming life sciences Pharmaceutical Technology
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year - Fierce Pharma
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market - Fierce Pharma
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market Fierce Pharma
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy Pharmaceutical Technology
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page